NCT02853318
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +28 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Fallopian Tube Clear Cell Adenocarcinoma
Explore clinical trials studying Fallopian Tube Clear Cell Adenocarcinoma. Study availability and eligibility vary by location and protocol.
20 public trials
3 recruiting studies
Fallopian Tube Clear Cell Adenocarcinoma trial results
NCT02315430
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
- Locations
-
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Regional Hospital Anchorage, Alaska, United States
NCT01504126
- Conditions
- Adnexal Diseases, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Diseases, +44 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Lyndon Baines Johnson General Hospital Houston, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States
- The Woman's Hospital of Texas Houston, Texas, United States
NCT01074411
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +41 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT00262847
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +48 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
Active, Not Recruiting
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
NCT04092270
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
- Locations
-
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
Active, Not Recruiting
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
NCT02068794
- Conditions
- Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +39 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02446600
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02502266
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Active, Not Recruiting
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States